Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
2,155,040
-
Share change
-
+575,803
-
Total reported value
-
$33,082,000
-
Price per share
-
$15.35
-
Number of holders
-
20
-
Value change
-
+$9,011,408
-
Number of buys
-
12
-
Number of sells
-
6
Institutional Holders of NEURODERM LTD - ORD SHS as of Q2 2015
As of 30 Jun 2015,
NEURODERM LTD - ORD SHS was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,155,040 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, venBio Select Advisor LLC, Longwood Capital Partners LLC, BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, MENORA MIVTACHIM HOLDINGS LTD., Foresite Capital Management II, LLC, Opaleye Management Inc., OPPENHEIMER & CO INC, and GOLDMAN SACHS GROUP INC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.